RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 ROCKET-AF: Rivaroxaban vs Warfarin in Patients with Moderate Renal Insufficiency
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 10
SP 25
OP 26
DO 10.1177/155989771110016
UL http://mdc.sagepub.com/content/11/10/25.abstract
AB Patients with atrial fibrillation and moderate renal dysfunction have a higher risk of stroke and bleeding than patients with normal renal function, but respond favorably to reduced-dose rivaroxaban compared with warfarin, according to new findings from the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibitor Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation [ROCKET-AF; NCT00403767].